Erleada 60 MG tablet UU 120S
Ended Awarded
- Contract number
- SPE2DB25FWWE2
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $7,559
Award facts
- Contract value 100% obligated
- $7,558.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Erleada 60 mg tablets in a quantity of 120 units, with a ceiling value of $7,558.78. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on August 11, 2025, with an ultimate completion date of September 2, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and running through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's extensive federal contract portfolio with DLA encompasses a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains. Erleada, an androgen receptor inhibitor used in oncology treatment, represents one of the specialized brand-name medications the company supplies through its prime vendor relationship. The delivery order structure and firm fixed pricing reflect standard federal procurement practices for pharmaceutical commodities, enabling the DLA to efficiently source medical supplies through an established contractor relationship that demonstrates proven capability to meet federal healthcare requirements.
Quick answers
Who was awarded contract SPE2DB25FWWE2?
SPE2DB25FWWE2 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FWWE2 worth?
The government has obligated $7,559 on SPE2DB25FWWE2.
Is contract SPE2DB25FWWE2 an order under another contract?
Yes. SPE2DB25FWWE2 is a delivery order under SPE2DB24D2018, an indefinite delivery contract.
Was contract SPE2DB25FWWE2 competed?
The extent of competition for SPE2DB25FWWE2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award